Skip to main content
OncoTargets and Therapy logoLink to OncoTargets and Therapy
. 2019 May 28;12:4223. doi: 10.2147/OTT.S213952

CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway [Corrigendum]

Z Feng, Q Chen, M Ren, Z Tian, Y Gong
PMCID: PMC6549415  PMID: 31213840

Feng Z, Chen Q, Ren M, Tian Z, Gong Y. OncoTargets Ther. 2019;12:3011–3017.

The author list and affiliations should be:

Zhongxin Feng,1 Qi Chen,1 Mingqiang Ren,1 Zuguo Tian,1 Yuping Gong2

1Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, People’s Republic of China; 2Department of Hematology, West China School of Medicine/West China Hospital, Sichuan University, Chengdu, People’s Republic of China

The corresponding author should be:

Correspondence: Qi Chen

Department of Hematology, Affiliated Hospital of Zunyi Medical University, No149, Dalian Road, Guizhou, Zunyi 563003, People’s Republic of China

Tel +86 851 2860 8538

Fax +86 851 2860 8538

Email zyfychenqi@163.com


Articles from OncoTargets and therapy are provided here courtesy of Dove Press

RESOURCES